Skip to main content

Biron Amin

Analyst

Piper Sandler

Equibles does not estimate personal net worth.

About Biron Amin

Biron Amin is recorded as Analyst at Piper Sandler. Biron Amin has spoken on 1 earnings call across 1 company, most recently for Kymera Therapeutics, Inc. on April 30, 2026. The companies whose calls Biron Amin spoke on are classified in the Healthcare sector.

Biron Amin on recent calls

“All right, so on Broad End 2, I noticed in the press release that you're also including adolescents in addition to adults in the trial, but I think more recently there was some inclusion criteria changes in the trial where you're now requiring, I think, adult patients.”
Analyst — Piper Sandler, Kymera Therapeutics, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Piper Sandler

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity